James Ring Name match only — unverified
Consultant · activity score 3
$30,819
paid as individual · 1 payer
3y
activity span (2022-2024)
Activity over time 3 year span
Committee-officer role
Candidate filing
IND-paid disbursement
Top payers 1 committee · $30,819 total
| Committee | Payments | Total |
|---|---|---|
| SCOTT FRANKLIN FOR CONGRESS | 13 | $30,819 |
Aggregated across all Schedule B IND payments to this name. Color: derived partisan lean of the paying committee (direct party_affiliation OR committee_partisan_lean.lean_score for super PACs).
Recent payments to this name last 13 · $30,819
| Date | Payer | Purpose | Amount |
|---|---|---|---|
| Nov 21, 2024 | SCOTT FRANKLIN FOR CONGRESS | TRAVEL: MILEAGE | $540 |
| Nov 15, 2024 | SCOTT FRANKLIN FOR CONGRESS | ADMINISTRATIVE CONSULTING | $1,000 |
| Nov 8, 2024 | SCOTT FRANKLIN FOR CONGRESS | ADMINISTRATIVE CONSULTING | $5,000 |
| Nov 17, 2022 | SCOTT FRANKLIN FOR CONGRESS | GENERAL CAMPAIGN CONSULTING | $5,000 |
| Nov 16, 2022 | SCOTT FRANKLIN FOR CONGRESS | TRAVEL: MILEAGE | $2,141 |
| Aug 25, 2022 | SCOTT FRANKLIN FOR CONGRESS | GENERAL POLITICAL CONSULTING | $6,029 |
| Aug 19, 2022 | SCOTT FRANKLIN FOR CONGRESS | GENERAL POLITICAL CONSULTING | $2,058 |
| Aug 10, 2022 | SCOTT FRANKLIN FOR CONGRESS | TRAVEL: MILEAGE | $1,791 |
| Aug 5, 2022 | SCOTT FRANKLIN FOR CONGRESS | GENERAL POLITICAL CONSULTING | $2,058 |
| Jul 29, 2022 | SCOTT FRANKLIN FOR CONGRESS | TRAVEL: MILEAGE | $942 |
| Jul 22, 2022 | SCOTT FRANKLIN FOR CONGRESS | GENERAL POLITICAL CONSULTING | $2,058 |
| Jul 13, 2022 | SCOTT FRANKLIN FOR CONGRESS | TRAVEL: MILEAGE | $146 |
| Jul 8, 2022 | SCOTT FRANKLIN FOR CONGRESS | GENERAL POLITICAL CONSULTING | $2,058 |
Disbursement rows where this name appears as the payee (schedule_b entity_tp='IND'). Name-matched, not identity-resolved — may include same-named individuals.
Geographic concentration 1 state
FL
1 payer cmte
Composite of candidate filings (cand.state) + states of distinct payer committees. Surfaces where the operative is geographically active.